HSK21542 is a novel, selective, peripherally-restricted KOR agonist, which is expected to be used for postoperative pain, as it rarely crosses the BBB, leading to a lower incidence of side effects in the CNS, such as hallucination, addiction and respiratory depression, being a candidate drug for treatment of both pain and pruritus (10). Here, OPRK1 is linked to respiratory depression.